Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjogren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas
Open Access
- 1 June 2004
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 43 (8) , 1050-1053
- https://doi.org/10.1093/rheumatology/keh248
Abstract
Objective. To determine the safety and therapeutic response of a regimen consisting of cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) plus rituximab in patients with Sjögren's syndrome (SS) and aggressive non-Hodgkin's lymphoma (NHL).Keywords
This publication has 0 references indexed in Scilit: